NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 11,260
+410 (3.78%)
Jun 30, 2026, 9:49 AM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 132.36 billion as of June 29, 2026.
Market Cap
132.36B
Enterprise Value
114.14B
Revenue
2.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,260.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has decreased from 232.96B to 132.36B, a decrease of -43.19%. That is a compound annual growth rate of -45.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 113.94B | -55.99% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 62.17T |
| Celltrion | 36.46T |
| ALTEOGEN | 18.40T |
| Samsung Epis Holdings | 10.61T |
| NeoImmuneTech | 124.57B |
| SAMSUNG PHARM. Co., LTD. | 120.10B |
| Kyongbo Pharmaceutical | 118.22B |
| AptaBio Therapeutics | 112.37B |